Dehydroepiandrosterone (DHEA) is a naturally occurring hormone that is produced primarily by the adrenal glands, which are located just above the kidneys. It serves as a precursor to other important hormones, including estrogen and testosterone, and plays a critical role in the body's endocrine system. DHEA levels peak in early adulthood and gradually decline with age, which has led to interest in its potential as a supplement for various health benefits.

DHEA is the most abundant circulating steroid hormone in humans and is also converted into its sulfated form, DHEA-S, which can be stored in the body and used as needed. The hormone is involved in a wide range of physiological processes, including immune function, metabolism, and sexual health. It is often referred to as a "prohormone" because of its role in the synthesis of other hormones.

As a supplement, DHEA is available in various forms, including tablets, capsules, and topical creams. It is marketed for a variety of potential benefits, including improving bone density, enhancing mood, increasing libido, and promoting overall well-being. The interest in DHEA supplementation has grown, particularly among older adults, due to its decline with age and its potential to counteract some age-related changes. The hormone has been studied extensively, but its efficacy and safety continue to be topics of ongoing research and debate.

DHEA is utilized for various health purposes, primarily because of its role as a precursor to sex hormones like estrogen and testosterone. One of the most common uses of DHEA is for combating age-related declines in hormone levels, particularly in older adults. Research suggests that DHEA supplementation might help improve bone density, particularly in postmenopausal women. A study published in "The Journal of Clinical Endocrinology and Metabolism" found that DHEA supplementation increased bone mineral density in the spine and hip, which are critical areas for preventing fractures (Elraiyah et al., 2014).

Another widely studied application of DHEA is its potential to improve mood and combat mild depression. Some research indicates that DHEA might have antidepressant effects, possibly due to its role in boosting levels of estrogen and testosterone. For instance, a study in "The Journal of Steroid Biochemistry and Molecular Biology" reported that DHEA administration led to significant improvements in mood and cognitive function in postmenopausal women (Pluchino et al., 2015). However, these findings are not universally consistent across all studies, and more research is needed to establish definitive conclusions.

DHEA is also explored for its potential benefits in cardiovascular health. Some evidence suggests that DHEA supplementation can positively influence lipid profiles by reducing total cholesterol and low-density lipoprotein (LDL) levels. However, a systematic review and meta-analysis published in "Nutrition, Metabolism, and Cardiovascular Diseases" indicated that while DHEA might reduce total cholesterol levels slightly, it could also lower high-density lipoprotein (HDL) levels, which could be counterproductive for cardiovascular health (Qin et al., 2020).

Sexual dysfunction is another area where DHEA has shown promise. Studies have found that DHEA supplementation can improve sexual function and libido, particularly in postmenopausal women. A study in "The Journal of Clinical Endocrinology and Metabolism" demonstrated that DHEA significantly improved sexual function and frequency in early postmenopausal women compared to vitamin D (Pluchino et al., 2015). However, similar benefits in men are less consistently reported, and the evidence is more mixed.

In summary, while DHEA is used for a variety of health concerns ranging from bone health to mood enhancement and sexual dysfunction, the scientific community does not unanimously agree on its efficacy. Studies show mixed results, and more robust, long-term research is necessary to fully understand the benefits and limitations of DHEA supplementation.

DHEA functions primarily as a precursor to other essential hormones, including estrogen and testosterone, which are crucial for various bodily functions. This means that DHEA itself may not have significant direct effects, but it can be converted into these more active hormones through enzymatic processes in different tissues. DHEA is produced in the adrenal glands, gonads, and brain, and it circulates in the bloodstream in both its free form and its sulfated form, DHEA-S. The sulfated form serves as a reservoir that can be converted back to DHEA as needed.

The conversion of DHEA into other hormones occurs through several enzymatic steps. For example, in peripheral tissues, DHEA can be converted into androstenedione, which can then be converted into testosterone or estrone. Testosterone can further be converted into dihydrotestosterone (DHT) or estradiol, depending on the specific needs of the tissue. This conversion process is known as intracrinology, where hormone synthesis and action occur within the same cell, allowing for localized control of hormone levels without significantly affecting systemic hormone concentrations.

DHEA also interacts with various receptors in the body. It can bind to androgen receptors, albeit with less affinity than testosterone, and exert weak androgenic effects. Additionally, DHEA can influence estrogen receptors either directly or through its conversion to estrogen, thereby impacting estrogenic activity in tissues such as the bone and brain. This dual capability to be converted into both androgens and estrogens allows DHEA to support a wide range of physiological processes, including bone density maintenance, immune function, and cognitive health.

Moreover, DHEA has been found to have neurosteroid properties, meaning it can influence brain function independently of its role as a hormone precursor. Research published in "The Journal of Steroid Biochemistry and Molecular Biology" suggests that DHEA can affect neuroprotection, neurite growth, neurogenesis, and neuronal survival (Pluchino et al., 2015). These effects are thought to be mediated through various mechanisms, including modulation of GABAergic and NMDA receptor activity, as well as interactions with sigma-1 receptors, which play a role in cell survival and neuroplasticity.

In summary, DHEA works by serving as a precursor to other hormones, interacting with specific receptors, and exerting neurosteroid effects. Its ability to be converted into both androgens and estrogens allows it to support a variety of bodily functions, making it a versatile component of the endocrine system. However, the complexity of its metabolic pathways and interactions means that the effects of DHEA supplementation can vary widely among individuals.

DHEA is used differently in men's and women's health primarily due to the distinct hormonal needs and physiological conditions of each gender. In women, DHEA supplementation is often focused on addressing issues related to menopause and hormonal imbalances. As women age, their levels of estrogen and testosterone decline, leading to symptoms such as hot flashes, vaginal dryness, reduced libido, and bone density loss. DHEA can serve as a precursor to both estrogen and testosterone, helping to alleviate these symptoms. For instance, studies have shown that DHEA supplementation can improve sexual function and reduce menopausal symptoms such as hot flashes and vaginal atrophy in postmenopausal women (Pluchino et al., 2015).

In men, DHEA is more commonly used to address issues related to aging, such as reduced testosterone levels, decreased muscle mass, and diminished libido. As men age, their DHEA levels decline, which can contribute to a decrease in testosterone production. Supplementing with DHEA can help boost testosterone levels, although the effects are often less pronounced compared to women. Some studies have shown that DHEA can help increase free testosterone levels, which may improve muscle mass, strength, and overall vitality (Collomp et al., 2018). However, the benefits are not universally observed, and the response to DHEA supplementation can vary widely among individuals.

Additionally, DHEA is sometimes used to support bone health in both men and women, but the mechanisms and outcomes can differ. In women, particularly postmenopausal women, DHEA can help improve bone mineral density by increasing estrogen levels, which play a critical role in maintaining bone health. In men, the effect of DHEA on bone health might be mediated through its conversion to testosterone, which also supports bone density. A study published in "The Journal of Clinical Endocrinology & Metabolism" found that DHEA supplementation improved bone mineral density in both men and women, although the effects were more pronounced in women (Elraiyah et al., 2014).

Moreover, DHEA has been studied for its potential effects on mood and cognitive function in both genders. In women, especially those going through menopause, DHEA has been shown to improve mood and cognitive function, potentially due to its conversion to estrogen and its neurosteroid effects (Pluchino et al., 2015). In men, the benefits on mood and cognitive function are less clear, and more research is needed to establish any significant effects.

In summary, DHEA is used differently in men’s and women’s health due to their distinct hormonal needs and physiological conditions. In women, it is primarily used to alleviate menopausal symptoms and improve bone health, while in men, it is often used to boost testosterone levels and support overall vitality. The response to DHEA supplementation can vary widely, and more research is needed to fully understand its benefits and mechanisms in both genders.

Determining the appropriate dosage of DHEA can be challenging due to the variability in individual responses and the specific health goals of the user. Generally, the recommended dosage of DHEA can range from 25 to 50 milligrams per day for most adults. However, some studies have used doses as high as 100 milligrams per day, particularly in older adults or those with specific health conditions. It is essential to start with a lower dose and gradually increase it as needed while monitoring for any side effects or adverse reactions.

For women, especially those experiencing menopausal symptoms, a common starting dose is around 25 milligrams per day. This dosage has been shown to help alleviate symptoms such as hot flashes, vaginal dryness, and reduced libido. In a study published in "The Journal of Clinical Endocrinology & Metabolism," a 25-milligram daily dose of DHEA was effective in improving bone mineral density and alleviating menopausal symptoms in postmenopausal women (Elraiyah et al., 2014). Some women may require higher doses, up to 50 milligrams per day, depending on their symptoms and individual response.

In men, the typical starting dose is also around 25 milligrams per day, with some studies suggesting that doses up to 50 milligrams per day can be beneficial for increasing testosterone levels, improving muscle mass, and enhancing overall vitality. A study in "Endocrine" found that a 50-milligram daily dose of DHEA effectively increased free testosterone levels in young, recreationally trained male athletes (Collomp et al., 2018). As with women, it is crucial for men to start with a lower dose and adjust as needed based on their response and any side effects.

It is important to note that higher doses of DHEA, such as 100 milligrams per day, should be used with caution and under the supervision of a healthcare professional. High doses may increase the risk of side effects, including acne, hair loss, and changes in mood. Additionally, long-term use of high-dose DHEA supplementation has not been well-studied, and its safety remains uncertain.

In summary, the appropriate dosage of DHEA can vary depending on individual needs and health goals. A common starting dose is 25 milligrams per day, with the possibility of increasing to 50 milligrams per day if needed. It is essential to monitor for side effects and consult with a healthcare professional before starting DHEA supplementation, especially if higher doses are being considered.

DHEA supplementation is generally well-tolerated, but like any supplement or medication, it can cause side effects, particularly when taken in higher doses or over extended periods. The side effects can vary based on individual sensitivity, dosage, and duration of use.

One of the most commonly reported side effects of DHEA is acne. This is due to its conversion into androgens like testosterone, which can increase sebum production and lead to clogged pores. Similarly, some people may experience oily skin or hair loss, particularly at higher doses. These effects are more likely in individuals who are already prone to acne or have a history of androgenic alopecia.

DHEA can also cause hormonal imbalances, leading to changes in mood and emotional well-being. Some users report experiencing irritability, mood swings, or increased anxiety. These mood changes are thought to be related to fluctuations in hormone levels, particularly if DHEA is converted to testosterone or estrogen in significant amounts.

In women, DHEA can sometimes cause symptoms of masculinization, such as a deeper voice, increased body hair (hirsutism), or menstrual irregularities. These effects are more common at higher doses and can be particularly concerning for women who are sensitive to androgens. Conversely, men might experience breast tenderness or gynecomastia (the development of breast tissue) due to the potential conversion of DHEA to estrogen.

Other potential side effects include gastrointestinal issues such as nausea, abdominal discomfort, or changes in bowel habits. Some people also report experiencing headaches or dizziness. While these side effects are generally mild and transient, they can be bothersome for some individuals.

Long-term use of DHEA, particularly at high doses, raises additional concerns. There is limited research on the long-term safety of DHEA supplementation, and some studies suggest potential risks such as liver toxicity or an increased risk of hormone-sensitive cancers (e.g., breast or prostate cancer). Therefore, it is essential to use DHEA under the guidance of a healthcare professional and to monitor for any adverse effects.

In summary, while DHEA supplementation can offer various health benefits, it is not without potential side effects. Common side effects include acne, oily skin, hair loss, mood changes, and gastrointestinal issues. Women may experience masculinization symptoms, while men might encounter estrogenic effects. Long-term safety remains a concern, particularly at higher doses, highlighting the importance of professional supervision and monitoring.

While DHEA can offer potential benefits, it is not suitable for everyone. Certain individuals should avoid DHEA supplementation due to potential risks and contraindications. Here are some groups of people who should not take DHEA:

1. Individuals with Hormone-Sensitive Conditions: People with a history of hormone-sensitive cancers, such as breast, ovarian, or prostate cancer, should avoid DHEA. This is because DHEA can convert to estrogen and testosterone, which may stimulate the growth of hormone-sensitive tumors. A study published in "The Journal of Clinical Endocrinology & Metabolism" suggests caution in using DHEA in individuals with these conditions due to the potential for hormonal stimulation (Elraiyah et al., 2014).
2. Pregnant and Breastfeeding Women: DHEA supplementation is not recommended for pregnant or breastfeeding women. The hormonal changes induced by DHEA could potentially affect fetal development or milk production. There is limited research on the safety of DHEA in these populations, so it is best to err on the side of caution.
3. Individuals with Liver Disease: Since DHEA is metabolized in the liver, those with liver disease or impaired liver function should avoid DHEA supplementation. There is a concern that DHEA could exacerbate liver conditions or lead to liver toxicity, particularly at higher doses.
4. Individuals with Mood Disorders: People with mood disorders such as bipolar disorder or severe depression should use caution with DHEA. Some studies have reported mood swings, increased anxiety, and irritability as side effects of DHEA supplementation. These effects could potentially worsen pre-existing mood disorders (Pluchino et al., 2015).
5. Individuals with Polycystic Ovary Syndrome (PCOS): Women with PCOS often have elevated levels of androgens, and adding DHEA to the mix could exacerbate symptoms such as hirsutism (excessive hair growth), acne, and menstrual irregularities. It is advisable for women with PCOS to consult with their healthcare provider before considering DHEA supplementation.
6. People with High Risk of Cardiovascular Disease: Although some studies suggest that DHEA may have positive effects on lipid profiles, others indicate potential negative impacts on HDL levels (Qin et al., 2020). Individuals with a high risk of cardiovascular disease should approach DHEA supplementation with caution and under medical supervision.

In summary, while DHEA can provide health benefits for some individuals, it is not suitable for everyone. Those with hormone-sensitive cancers, pregnant or breastfeeding women, individuals with liver disease, mood disorders, PCOS, and those at high risk for cardiovascular disease should avoid DHEA supplementation or use it only under strict medical supervision. As always, consulting with a healthcare professional before starting any new supplement is crucial to ensure safety and appropriateness for your specific health needs.

Yes, DHEA supplements are known to interact with several medications, which can potentially alter the effectiveness of the drugs or lead to adverse effects. It is important for individuals taking prescription medications to consult with their healthcare provider before starting DHEA supplementation. Here are some of the known interactions:

1. Hormone Replacement Therapy (HRT): DHEA can interact with estrogen or testosterone replacement therapies. Since DHEA is a precursor to these hormones, taking it alongside HRT can lead to excessive levels of estrogen or testosterone, potentially resulting in side effects such as hormonal imbalances, mood swings, and increased risk of hormone-sensitive cancers (Elraiyah et al., 2014).
2. Antidepressants: DHEA may interact with certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). This interaction can potentially exacerbate side effects such as mood swings, anxiety, or insomnia. A study in "Psychoneuroendocrinology" highlighted the need for caution when combining DHEA with psychiatric medications, as it can influence mood and cognitive function (Misiak et al., 2018).
3. Antidiabetic Medications: DHEA can affect blood sugar levels and insulin sensitivity, which may interfere with antidiabetic medications such as metformin or insulin. For individuals with diabetes, it is crucial to monitor blood sugar levels closely and consult with a healthcare provider before starting DHEA supplementation.
4. Anticoagulants and Antiplatelet Drugs: DHEA can potentially interact with blood-thinning medications like warfarin, aspirin, and clopidogrel. This interaction may either enhance or reduce the effectiveness of these drugs, increasing the risk of bleeding or clotting. It is important for individuals on anticoagulant therapy to seek medical advice before using DHEA.
5. Corticosteroids: DHEA may counteract the effects of corticosteroids like prednisone, which are often used to treat inflammatory and autoimmune conditions. Since DHEA has anti-inflammatory properties, it could interfere with the intended action of corticosteroids, potentially reducing their efficacy.
6. Anticonvulsants: Medications used to treat epilepsy, such as phenytoin or carbamazepine, may interact with DHEA. These interactions can affect the metabolism of DHEA and the anticonvulsant drug, potentially leading to altered drug levels and effectiveness.

In summary, DHEA supplements can interact with various medications, including hormone replacement therapies, antidepressants, antidiabetic drugs, anticoagulants, corticosteroids, and anticonvulsants. These interactions can lead to altered drug effectiveness or increased risk of side effects. It is essential for individuals taking prescription medications to consult with their healthcare provider before starting DHEA supplementation to ensure safety and avoid potential adverse interactions.

When it comes to obtaining DHEA, there are several sources to consider, each with its own advantages and considerations. DHEA is primarily available as a dietary supplement, but there are also natural ways to support your body's production of this hormone. Here are the best sources of DHEA:

1. Dietary Supplements: The most common and direct way to increase DHEA levels is through dietary supplements. These are available over-the-counter in various forms, including tablets, capsules, and topical creams. Supplements are typically synthesized from plant sources like soy or wild yam. It's essential to choose high-quality products from reputable manufacturers to ensure purity and potency. Look for supplements that have been third-party tested for quality assurance.
2. Prescription DHEA: In some countries, DHEA is available by prescription for specific medical conditions, such as adrenal insufficiency. Prescription DHEA is typically of higher quality and purity compared to over-the-counter supplements. If you have a medical condition that warrants DHEA supplementation, it is advisable to consult with a healthcare provider to obtain a prescription product.
3. Dietary Sources: While DHEA itself is not found in significant amounts in food, certain dietary practices can support your body's natural production of the hormone. A balanced diet rich in essential nutrients, healthy fats, and proteins can help maintain optimal hormone levels. Foods that support adrenal health, such as lean meats, fish, nuts, seeds, and green leafy vegetables, can indirectly support DHEA production.
4. Lifestyle Factors: Engaging in regular physical activity, managing stress, and getting adequate sleep are crucial for maintaining healthy DHEA levels. Chronic stress and poor sleep can deplete adrenal function, leading to lower DHEA production. Practices such as mindfulness, yoga, and stress management techniques can help support adrenal health and, consequently, DHEA levels.
5. Bioidentical Hormone Therapy: For individuals with significantly low DHEA levels or specific medical conditions, bioidentical hormone therapy may be an option. This therapy involves the use of hormones that are chemically identical to those produced by the human body. Bioidentical DHEA is often prescribed by healthcare professionals specializing in hormone replacement therapy.

In summary, the best sources of DHEA include dietary supplements, prescription DHEA, and supportive dietary and lifestyle practices. For those with specific medical needs, bioidentical hormone therapy may be an option. It is essential to choose high-quality supplements and consult with a healthcare provider to determine the most appropriate source and dosage for your individual needs.

DHEA is available in several forms, each with its own advantages and specific applications. The form you choose can depend on your health goals, convenience, and any recommendations from your healthcare provider. Here are the primary forms of DHEA:

1. Oral Tablets and Capsules: The most common form of DHEA supplementation is oral tablets or capsules. These are easy to take and widely available over-the-counter in various dosages, typically ranging from 25 to 100 milligrams. Oral forms are convenient for daily use and are often recommended for general health benefits, including improved mood, energy levels, and hormone balance. However, the bioavailability of oral DHEA can vary, and some of the hormone might be metabolized by the liver before it reaches systemic circulation.
2. Topical Creams and Gels: Topical DHEA creams and gels are applied directly to the skin, where the hormone is absorbed into the bloodstream. This form can be particularly beneficial for individuals who have difficulty with oral supplements or who want to target specific areas. Topical applications can provide a more consistent release of DHEA into the body and may minimize the first-pass metabolism by the liver. They are often used for localized benefits, such as improving skin health and elasticity or addressing vaginal dryness in postmenopausal women.
3. Sublingual Tablets and Liquids: Sublingual forms of DHEA are designed to be placed under the tongue, where they dissolve and are absorbed directly into the bloodstream through the mucous membranes. This method can offer faster absorption compared to oral tablets and may provide more immediate effects. Sublingual forms are available as tablets or liquid drops and are a good option for those seeking quick results or who have digestive issues that affect the absorption of oral supplements.
4. Injectable DHEA: In some clinical settings, DHEA may be administered via injection. This form ensures the hormone is delivered directly into the bloodstream, bypassing the digestive system entirely. Injectable DHEA is typically used under medical supervision for specific medical conditions, such as adrenal insufficiency. It is not commonly used for general supplementation due to the need for professional administration and potential discomfort.
5. Vaginal Suppositories: For women dealing with vaginal atrophy or dryness, particularly postmenopausal women, DHEA vaginal suppositories can be an effective form. These are inserted directly into the vagina, where they release DHEA locally to improve vaginal health and alleviate symptoms such as dryness and discomfort during intercourse. This method targets the affected area directly and minimizes systemic hormone exposure.

In summary, DHEA is available in various forms, including oral tablets and capsules, topical creams and gels, sublingual tablets and liquids, injectable forms, and vaginal suppositories. Each form has its unique benefits and applications, and the choice of form can depend on individual health goals, convenience, and any specific recommendations from a healthcare provider. As always, it is important to consult with a healthcare professional before starting any new supplement regimen.

DHEA itself is a precursor hormone that is metabolized into several active sub-compounds, which are critical to its efficacy in the body. These sub-compounds include androgens and estrogens, which are essential for a wide range of physiological functions. Understanding the roles of these metabolites can help elucidate how DHEA exerts its effects.

1. Androstenedione and Androstenediol: These are intermediate metabolites of DHEA that can be further converted into testosterone and estrone. Androstenedione is a key precursor for testosterone synthesis, particularly in peripheral tissues such as the skin, liver, and adipose tissue. Androstenediol, on the other hand, can be converted into both testosterone and estradiol. These conversions are critical for maintaining androgen and estrogen levels, which support various bodily functions, including muscle mass, bone density, and sexual health.
2. Testosterone: One of the most well-known metabolites of DHEA, testosterone is a potent androgen that plays a crucial role in muscle growth, bone density, libido, and overall energy levels. In men, testosterone is primarily produced in the testes, but in women, a significant portion of testosterone is derived from DHEA. Studies have shown that DHEA supplementation can increase testosterone levels, particularly in women, thereby contributing to improved muscle mass, libido, and well-being (Hu et al., 2020).
3. Dihydrotestosterone (DHT): DHT is a more potent androgen derived from testosterone. It has a significant role in the development of male characteristics and is also involved in maintaining prostate health and hair growth. While DHEA can indirectly lead to increased DHT levels through its conversion to testosterone, excessive DHT can also be associated with conditions like androgenic alopecia (hair loss) and prostate enlargement. Therefore, the balance of DHEA metabolism is crucial.
4. Estrone and Estradiol: These are the primary estrogenic metabolites of DHEA. Estrone is a weaker estrogen compared to estradiol but can be converted into estradiol, the most potent estrogen. These estrogens are vital for maintaining bone density, cardiovascular health, and reproductive tissues. In postmenopausal women, DHEA serves as a significant source of estrogen, which can help alleviate menopausal symptoms such as hot flashes, vaginal dryness, and reduced bone density (Pluchino et al., 2015).
5. 7-Keto DHEA: This is a metabolite of DHEA that does not convert into androgens or estrogens, thus avoiding the hormonal side effects associated with its parent compound. 7-Keto DHEA is often marketed as a safer alternative for weight loss and enhancing metabolism. It has been studied for its potential to improve immune function and increase metabolic rate without affecting hormone levels.

In summary, the efficacy of DHEA is largely dependent on its metabolism into various sub-compounds, including androstenedione, androstenediol, testosterone, DHT, estrone, and estradiol. These metabolites are critical for the hormone's diverse effects on muscle mass, bone density, sexual health, and overall well-being. Additionally, 7-Keto DHEA offers a non-hormonal pathway for some of DHEA's benefits. Understanding these sub-compounds helps elucidate how DHEA functions in the body and guides its use in supplementation.

DHEA, or dehydroepiandrosterone, is known by several other names, abbreviations, and chemical designations. These alternative names and spellings can be useful to know, especially when looking for information or products related to this hormone. Here are some of the common names, misspellings, abbreviations, and chemical compounds associated with DHEA:

1. Common Abbreviations:
   • DHEA: The most widely used abbreviation for dehydroepiandrosterone.
   • DHEA-S: Refers to dehydroepiandrosterone sulfate, the sulfated form of DHEA that is stored in the body and converted back to DHEA as needed.
2. Chemical Names:
   • Prasterone: Another name for DHEA, often used in scientific literature and some medical contexts.
   • 3β-Hydroxyandrost-5-en-17-one: The full chemical name of DHEA, describing its molecular structure.
   • Androstenolone: Another chemical name for DHEA, reflecting its role as a precursor to androgens.
3. Common Misspellings:
   • Dehydroepiandosterone: A common misspelling that mistakenly adds an "and" in the middle.
   • Dehydroepiandrostereone: Another misspelling, with an extra "r" inserted before the "eone" suffix.
   • DHEAS: Sometimes written as a single word without the hyphen, though this generally refers to the sulfated form.
4. Alternative Names:
   • Dehydroisoandrosterone: Another variant name sometimes used in scientific contexts.
   • Transdehydroandrosterone: A less common name that may appear in certain biochemical studies.
5. Ingredients in Supplements:
   • Wild Yam Extract: While wild yam itself does not contain DHEA, it is often used in the synthesis of DHEA supplements. Some products may list wild yam extract as an ingredient, contributing to the misconception that it naturally contains DHEA.
   • Soy Extract: Similar to wild yam, soy is another plant source used in the manufacturing of synthetic DHEA supplements.
6. Other Related Compounds:
   • 7-Keto DHEA: A metabolite of DHEA that does not convert to estrogen or testosterone, often marketed for weight loss and metabolic benefits.
   • Androstenedione: A direct precursor of testosterone and estrogen, derived from DHEA.

In summary, DHEA is also known as prasterone, 3β-hydroxyandrost-5-en-17-one, and androstenolone, among other names. Common abbreviations include DHEA and DHEA-S, and it is sometimes misspelled as dehydroepiandosterone or dehydroepiandrostereone. Understanding these alternative names and related compounds can help in identifying DHEA products and information accurately.

When choosing a DHEA supplement, it is crucial to examine the label carefully to ensure you are selecting a high-quality product. Here are key factors to look for on the label:

1. Dosage and Concentration: Check for the amount of DHEA per serving. Common dosages range from 25 mg to 100 mg per tablet or capsule. Ensure the dosage aligns with your needs and any recommendations from a healthcare provider. Avoid products that do not clearly state the amount of DHEA per serving.
2. Third-Party Testing: Look for supplements that have been third-party tested for purity and potency. Certifications from organizations such as NSF International, United States Pharmacopeia (USP), or ConsumerLab indicate that the product has been independently tested for quality assurance. Third-party testing helps ensure that the supplement contains the stated amount of DHEA and is free from contaminants.
3. Ingredients List: Review the list of ingredients to ensure there are no unwanted additives, fillers, or artificial ingredients. A high-quality DHEA supplement should have a minimal ingredient list, primarily consisting of the active ingredient (DHEA) and necessary excipients like cellulose or magnesium stearate. Avoid products with unnecessary additives or proprietary blends that do not disclose specific ingredient amounts.
4. Form of DHEA: Ensure the label specifies the form of DHEA used in the supplement. For instance, some products may contain DHEA sulfate (DHEA-S) or 7-Keto DHEA, a metabolite of DHEA that does not convert to sex hormones. Choose the form that best suits your health goals and needs.
5. Manufacturer Information: Check for the manufacturer's name and contact information. Reputable companies will provide clear contact details and will often have a website where you can find more information about their manufacturing processes and quality control standards. Look for brands with a good reputation and positive reviews.
6. Expiration Date: Ensure the product has a clearly marked expiration date. Supplements can lose potency over time, so it is important to choose a product that is within its shelf life to ensure maximum efficacy.
7. Allergen Information: If you have allergies or sensitivities, check the label for potential allergens. Look for statements such as "free from gluten, dairy, soy, and artificial preservatives" to ensure the product is safe for you to use.
8. Recommended Use: The label should include clear instructions on how to take the supplement, including the recommended dosage and any specific instructions (e.g., take with food). This information helps ensure you use the product correctly for optimal results.
9. Warnings and Precautions: Look for any warnings or precautions related to the use of DHEA. This may include advisories for pregnant or breastfeeding women, individuals with hormone-sensitive conditions, or those taking specific medications. This information can help you determine if the supplement is safe for you to use.

In summary, when choosing a DHEA supplement, look for clear dosage information, third-party testing certifications, a minimal and transparent ingredient list, the specific form of DHEA, reputable manufacturer details, an expiration date, allergen information, recommended use instructions, and relevant warnings or precautions. These factors can help you select a high-quality product that meets your needs and ensures safety and efficacy.

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

1. Ying Qin, Heitor O Santos, Vahid Khani, S. C. Tan, Yingpeng Zhi (2020). Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.. Nutrition, metabolism, and cardiovascular diseases : NMCD, , . Link: 10.1016/j.numecd.2020.05.015
2. Ying Hu, P. Wan, X-Q An, Guilin Jiang (2020). Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A dose-response meta-analysis of randomized controlled trials.. Complementary therapies in medicine, ,
   102620 . Link: 10.1016/j.ctim.2020.102620
3. P. Kroboth, F. Salek, A. Pittenger, T. Fabian, R. Frye (1999). DHEA and DHEA‐S: A Review. The Journal of Clinical Pharmacology, 39, . Link: 10.1177/00912709922007903
4. J. Jančić, Nemanja Nenezić, S. Kostic, D. S. Štrac, Marija Grunauer, Dragan S. Nenezić, Milica Radosavljevic, J. Jančić (2022). Dehydroepiandrosterone (Dhea): Pharmacological Effects And Potential Therapeutic Application.. Mini reviews in medicinal chemistry, , . Link: 10.2174/1389557522666220919125817
5. N. Pluchino, P. Drakopoulos, Francesco Bianchi-Demicheli, J. Wenger, Patrick Petignat, A. Genazzani (2015). Neurobiology of DHEA and effects on sexuality, mood and cognition. The Journal of Steroid Biochemistry and Molecular Biology, 145, 273-280. Link: 10.1016/j.jsbmb.2014.04.012
6. K. Aoki, Kazuki Tajima, M. Taguri, Y. Terauchi (2016). Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1−/−, and IRS2−/− male mice fed a high-fat diet. The Journal of Steroid Biochemistry and Molecular Biology, 159, 110-120. Link: 10.1016/j.jsbmb.2016.03.011
7. Tarig A. Elraiyah, M. Sonbol, Zhen Wang, Tagwa Khairalseed, Noor Asi, C. Undavalli, M. Nabhan, Osama Altayar, L. Prokop, V. Montori, M. Murad (2014). Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.. The Journal of clinical endocrinology and metabolism, 99 10,
   3536-42 . Link: 10.1210/jc.2014-2261
8. B. Allolio, W. Arlt (2002). DHEA treatment: myth or reality?. Trends in Endocrinology & Metabolism, 13, 288-294. Link: 10.1016/S1043-2760(02)00617-3
9. A. Traish, H. Kang, Farid Saad, Farid Saad, Andre T. Guay, Andre T. Guay (2011). Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.. The journal of sexual medicine, 8 11,
   2960-82; quiz 2983 . Link: 10.1111/j.1743-6109.2011.02523.x
10. Xiaoxue Wang, Helong Feng, De-Hui Fan, Guoliang Zou, Yu-Bo Han, Li Liu (2020). The influence of dehydroepiandrosterone (DHEA) on fasting plasma glucose, insulin levels and insulin resistance (HOMA-IR) index: A systematic review and dose response meta-analysis of randomized controlled trials.. Complementary therapies in medicine, 55,
    102583 . Link: 10.1016/J.CTIM.2020.102583
11. Antonella Pinto, Beatrice Malacrida, J. Oieni, M. M. Serafini, A. Davin, V. Galbiati, E. Corsini, M. Racchi (2015). DHEA modulates the effect of cortisol on RACK1 expression via interference with the splicing of the glucocorticoid receptor. British Journal of Pharmacology, 172, . Link: 10.1111/bph.13097
12. J. V. Niekerk, F. Huppert, J. Herbert (2001). Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology, 26, 591-612. Link: 10.1016/S0306-4530(01)00014-2
13. Hu Chen, Zhao Jin, Changliang Sun, Heitor O. Santos, H. Kord Varkaneh (2021). Effects of dehydroepiandrosterone (DHEA) supplementation on cortisol, leptin, adiponectin, and liver enzyme levels: A systematic review and meta‐analysis of randomised clinical trials. International Journal of Clinical Practice, 75, . Link: 10.1111/ijcp.14698
14. Hayley S. Kamin, Darlene A. Kertes (2017). Cortisol and DHEA in development and psychopathology. Hormones and Behavior, 89, 69-85. Link: 10.1016/j.yhbeh.2016.11.018
15. R. H. Straub, A. Schuld, Janet Mullington, M. Haack, J. Schölmerich, T. Pollmächer (2002). The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects.. The Journal of endocrinology, 175 2,
    467-74 . Link: 10.1677/JOE.0.1750467
16. P. Kroboth, J. Amico, R. Stone, M. Folan, R. Frye, F. Kroboth, K. Bigos, T. Fabian, A. M. Linares, B. Pollock, Charles Hakala (2003). Influence of DHEA Administration on 24-Hour Cortisol Concentrations. Journal of Clinical Psychopharmacology, 23, 96-99. Link: 10.1097/00004714-200302000-00014
17. E. Guazzo, P. Kirkpatrick, I. Goodyer, H. Shiers, J. Herbert (1996). Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.. The Journal of clinical endocrinology and metabolism, 81 11,
    3951-60 . Link: 10.1210/JCEM.81.11.8923843
18. S. Kalmijn, L. Launer, R. Stolk, F. D. Jong, H. Pols, A. Hofman, M. Breteler, S. Lamberts (1998). A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly.. The Journal of clinical endocrinology and metabolism, 83 10,
    3487-92 . Link: 10.1210/JCEM.83.10.5164
19. Lucy S. King, Madelaine G. Graber, Natalie L. Colich, I. Gotlib (2020). Associations of waking cortisol with DHEA and testosterone across the pubertal transition: Effects of threat-related early life stress. Psychoneuroendocrinology, 115, . Link: 10.1016/j.psyneuen.2020.104651
20. L. Topor, M. Asai, J. Dunn, J. Majzoub (2010). Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2.. The Journal of clinical endocrinology and metabolism, 96 1,
    E31-9 . Link: 10.1210/jc.2010-0692
21. J. Arnold, H. Le, K. Mcfann, M. Blackman (2005). Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.. American journal of physiology. Endocrinology and metabolism, 288 3,
    E573-84 . Link: 10.1152/AJPENDO.00454.2004
22. P. Sgrò, C. Minganti, M. Lista, C. Antinozzi, M. Cappa, Y. Pitsiladis, F. Pigozzi, L. Di Luigi (2020). Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase’s type 5 inhibitors on DHT response to exercise-related stress. Journal of Endocrinological Investigation, 44, 1219 - 1228. Link: 10.1007/s40618-020-01409-z
23. Gregory A. Brown, M. Vukovich, Rick L. Sharp, Tracy A. Reifenrath, Kerry A. Parsons, Douglas S. King (1999). Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men.. Journal of applied physiology, 87 6,
    2274-83 . Link: 10.1152/JAPPL.1999.87.6.2274
24. Ying Qin, Heitor O Santos, Vahid Khani, S. C. Tan, Yingpeng Zhi (2020). Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.. Nutrition, metabolism, and cardiovascular diseases : NMCD, , . Link: 10.1016/j.numecd.2020.05.015
25. M. Kohut, James R. Thompson, Jeff Campbell, G. A. Brown, M. Vukovich, D. Jackson, D. King (2003). Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men. Journal of the American College of Nutrition, 22, 363 - 371. Link: 10.1080/07315724.2003.10719319
26. Qianxing Mo, Shi-fang Lu, Carrie Garippa, M. Brownstein, N. Simon (2009). Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. The Journal of Steroid Biochemistry and Molecular Biology, 114, 135-143. Link: 10.1016/j.jsbmb.2009.01.015
27. Koji Sato, M. Iemitsu, K. Aizawa, R. Ajisaka (2008). Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle.. American journal of physiology. Endocrinology and metabolism, 294 5,
    E961-8 . Link: 10.1152/ajpendo.00678.2007
28. Koji Sato, M. Iemitsu, K. Aizawa, N. Mesaki, R. Ajisaka, S. Fujita (2012). DHEA administration and exercise training improves insulin resistance in obese rats. Nutrition & Metabolism, 9, 47 - 47. Link: 10.1186/1743-7075-9-47
29. V. Steele, J. Arnold, H. Lei, G. Izmirlian, M. Blackman (2006). Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.. Anticancer research, 26 5A,
    3205-15 . Link:
30. K. Collomp, C. Buisson, Nicolas Gravisse, Soraya Belgherbi, Z. Labsy, M. Do, O. Gagey, S. Dufay, N. Vibarel-Rebot, M. Audran (2018). Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine, 59, 538-546. Link: 10.1007/s12020-017-1514-z
31. Yan Zhu, L. Qiu, Fangfang Jiang, M. Găman, Ohoud Abudoraehem, K. Okunade, Ming Zhang (2021). The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials. Steroids, 173, . Link: 10.1016/j.steroids.2021.108889
32. Gregory A. Brown, M. Vukovich, Rick L. Sharp, Tracy A. Reifenrath, Kerry A. Parsons, Douglas S. King (1999). Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men.. Journal of applied physiology, 87 6,
    2274-83 . Link: 10.1152/JAPPL.1999.87.6.2274
33. C. Engdahl, M. Lagerquist, A. Stubelius, A. Andersson, E. Studer, C. Ohlsson, L. Westberg, H. Carlsten, H. Forsblad-d’Elia (2014). Role of androgen and estrogen receptors for the action of dehydroepiandrosterone (DHEA).. Endocrinology, 155 3,
    889-96 . Link: 10.1210/en.2013-1561
34. F. Labrie, L. Cusan, José-luis Gomez, I. Côté, R. Bérubé, P. Bélanger, C. Martel, C. Labrie (2008). Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology, 111, 178-194. Link: 10.1016/j.jsbmb.2008.06.003
35. F. Labrie (2019). Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues. Menopause, 26, 220–224. Link: 10.1097/GME.0000000000001177
36. F. Labrie, V. Luu‐The, C. Labrie, A. Bélanger, J. Simard, Sheng-Xiang Lin, G. Pelletier (2003). Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.. Endocrine reviews, 24 2,
    152-82 . Link: 10.1210/ER.2001-0031
37. K. Miller, N. Al-Rayyan, Margarita M. Ivanova, K. Mattingly, S. Ripp, C. Klinge, R. Prough (2013). DHEA metabolites activate estrogen receptors alpha and beta. Steroids, 78, 15-25. Link: 10.1016/j.steroids.2012.10.002
38. F. Labrie, V. Luu‐The, A. Bélanger, S. Lin, J. Simard, G. Pelletier, C. Labrie (2005). Is dehydroepiandrosterone a hormone?. The Journal of endocrinology, 187 2,
    169-96 . Link: 10.1677/JOE.1.06264
39. F. Labrie, V. Luu‐The, C. Labrie, J. Simard (2001). DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: Intracrinology. Frontiers in Neuroendocrinology, 22, 185-212. Link: 10.1006/frne.2001.0216
40. M. Panjari, S. Davis (2010). DHEA for postmenopausal women: a review of the evidence.. Maturitas, 66 2,
    172-9 . Link: 10.1016/j.maturitas.2009.12.017
41. Meixiang Zhang, W. Niu, Yu Wang, Jiawei Xu, Xiao Bao, Linlin Wang, Linqing Du, Ying-pu Sun (2016). Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis. Journal of Assisted Reproduction and Genetics, 33, 981-991. Link: 10.1007/s10815-016-0713-5
42. M. Sönmezer, B. Özmen, Aylin Pelin Cil, S. Ozkavukcu, Tolga Tasci, H. Olmus, C. Atabekoğlu (2009). Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders.. Reproductive biomedicine online, 19 4,
    508-13 . Link: 10.1016/J.RBMO.2009.06.006
43. J. Qin, L. Fan, A. Qin (2017). The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis.. Journal of gynecology obstetrics and human reproduction, 46 1,
    1-7 . Link: 10.1016/j.jgyn.2016.01.002
44. N. Gleicher, D. Barad (2011). Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reproductive Biology and Endocrinology : RB&E, 9, 67 - 67. Link: 10.1186/1477-7827-9-67
45. Chyi-uei Chern, K. Tsui, S. Vitale, San-Nung Chen, Peng-Hui Wang, A. Cianci, H. Tsai, Z. Wen, Li-Te Lin (2018). Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study. Reproductive Biology and Endocrinology : RB&E, 16, . Link: 10.1186/s12958-018-0409-z
46. Mazen R. Fouany, F. Sharara (2013). Is there a role for DHEA supplementation in women with diminished ovarian reserve?. Journal of Assisted Reproduction and Genetics, 30, 1239-1244. Link: 10.1007/s10815-013-0018-x
47. N. Gleicher, A. Weghofer, D. Barad (2010). Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reproductive Biology and Endocrinology : RB&E, 8, 140 - 140. Link: 10.1186/1477-7827-8-140
48. Amarin Narkwichean, W. Maalouf, M. Baumgarten, L. Polanski, N. Raine-Fenning, B. Campbell, K. Jayaprakasan (2017). Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.. European journal of obstetrics, gynecology, and reproductive biology, 218,
    39-48 . Link: 10.1016/j.ejogrb.2017.09.006
49. Y. Mahmoud, A. Mahmoud, Faten S. Abo-Zeid, N. Fares (2018). Effects of dehydroepiandrosterone on the ovarian reserve and pregnancy outcomes in perimenopausal rats (DHEA and fertility in perimenopausal rats). Life Sciences, 199, 131–138. Link: 10.1016/j.lfs.2018.03.021
50. A. Wiser, O. Gonen, Y. Ghetler, T. Shavit, A. Berkovitz, A. Shulman (2010). Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study.. Human reproduction, 25 10,
    2496-500 . Link: 10.1093/humrep/deq220
51. K. Nair, R. Rizza, P. O'brien, K. Dhatariya, K. Short, A. Nehra, J. Vittone, G. Klee, A. Basu, R. Basu, C. Cobelli, G. Toffolo, C. Dalla Man, D. Tindall, L. Melton, Glenn E. Smith, S. Khosla, M. Jensen (2006). DHEA in elderly women and DHEA or testosterone in elderly men.. The New England journal of medicine, 355 16,
    1647-59 . Link: 10.1056/NEJMOA054629
52. M. Kohut, James R. Thompson, Jeff Campbell, G. A. Brown, M. Vukovich, D. Jackson, D. King (2003). Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men. Journal of the American College of Nutrition, 22, 363 - 371. Link: 10.1080/07315724.2003.10719319
53. K. Collomp, C. Buisson, Nicolas Gravisse, Soraya Belgherbi, Z. Labsy, M. Do, O. Gagey, S. Dufay, N. Vibarel-Rebot, M. Audran (2018). Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine, 59, 538-546. Link: 10.1007/s12020-017-1514-z
54. A. Damgaard-Olesen, T. H. Johannsen, S. A. Holmboe, T. Søeborg, J. Petersen, Andersson Am, M. Aadahl, A. Linneberg, A. Juul (2016). Reference ranges of 17-hydroxyprogesterone, DHEA, DHEAS, androstenedione, total and free testosterone determined by TurboFlow-LC-MS/MS and associations to health markers in 304 men.. Clinica chimica acta; international journal of clinical chemistry, 454,
    82-8 . Link: 10.1016/j.cca.2015.12.042
55. C. André, A. Berthelot, J. Robert, M. Thomassin, Y. Guillaume (2003). Testimony of the correlation between DHEA and bioavailable testosterone using a biochromatographic concept: effect of two salts.. Journal of pharmaceutical and biomedical analysis, 33 5,
    911-21 . Link: 10.1016/S0731-7085(03)00428-X
56. S. Ferrando, J. Rabkin, L. Poretsky (1999). Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year.. Journal of acquired immune deficiency syndromes, 22 2,
    146-54 . Link: 10.1097/00126334-199910010-00006
57. B. Misiak, D. Frydecka, Olga Loska, A. Moustafa, J. Samochowiec, J. Kasznia, B. Stańczykiewicz (2018). Testosterone, DHEA and DHEA-S in patients with schizophrenia: A systematic review and meta-analysis. Psychoneuroendocrinology, 89, 92-102. Link: 10.1016/j.psyneuen.2018.01.007
58. Gregory A. Brown, M. Vukovich, Rick L. Sharp, Tracy A. Reifenrath, Kerry A. Parsons, Douglas S. King (1999). Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men.. Journal of applied physiology, 87 6,
    2274-83 . Link: 10.1152/JAPPL.1999.87.6.2274
59. H. C. Coelingh Bennink, Y. Zimmerman, E. Laan, Hanneke M M Termeer, N. Appels, A. Albert, B. Fauser, J. Thijssen, R. V. van Lunsen (2017). Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.. Contraception, 96 5,
    322-329 . Link: 10.1016/j.contraception.2016.06.022
60. Te-Chih Liu, Che-Hung Lin, Chih-Yang Huang, J. Ivy, C. Kuo (2013). Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. European Journal of Applied Physiology, 113, 1783 - 1792. Link: 10.1007/s00421-013-2607-x
61. A. Morales, J. Nolan, J. Nelson, S. S. Yen (1994). Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.. The Journal of clinical endocrinology and metabolism, 78 6,
    1360-7 . Link: 10.1210/JCEM.78.6.7515387
62. M. Xie, Yan Zhong, Q. Xue, Meirong Wu, Xiaoxian Deng, Heitor O. Santos, S. C. Tan, H. Kord-Varkaneh, P. Jiao (2020). Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials. Experimental Gerontology, 136, . Link: 10.1016/j.exger.2020.110949
63. Z. Yan, G. Lee, E. Anderson (1997). Influence of dehydroepiandrosterone on the expression of insulin-like growth factor-1 during cystogenesis in polycystic rat ovaries and in cultured rat granulosa cells.. Biology of reproduction, 57 6,
    1509-16 . Link: 10.1095/BIOLREPROD57.6.1509
64. M. Ribeiro, L. Garcia-Segura (2002). Dehydroepiandrosterone regulates insulin-like growth factor-1 system in adult rat hypothalamus. Endocrine, 17, 129-134. Link: 10.1385/ENDO:17:2:129
65. A. Genazzani, M. Stomati, C. Strucchi, Simone Puccetti, Stefano Luisi, A. Genazzani (2001). Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.. Fertility and sterility, 76 2,
    241-8 . Link: 10.1016/S0015-0282(01)01902-1
66. C. Luppi, M. Fioravanti, B. Bertolini, M. Inguscio, A. Grugnetti, F. Guerriero, C. Rovelli, F. Cantoni, P. Guagnano, E. Marazzi, E. Rolfo, D. Ghianda, D. Levante, C. Guerrini, R. Bonacasa, S. B. Solerte (2009). Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS).. Archives of gerontology and geriatrics, 49 Suppl 1,
    173-84 . Link: 10.1016/j.archger.2009.09.027
67. E. Willis, R. Wolf, G. White, D. McFarlane (2014). Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis).. General and comparative endocrinology, 195,
    21-7 . Link: 10.1016/j.ygcen.2013.10.004
68. F. Antonini, E. Petruzzi, P. Pinzani, C. Orlando, I. Petruzzi, M. Pazzagli, G. Masotti (2005). Effect of diet and red wine consumption on serum total antioxidant capacity (TAC), dehydroepiandrosterone-sulphate (DHEAS) and insulin-like growth factor-1 (IGF-1) in Italian centenarians.. Archives of gerontology and geriatrics, 41 2,
    151-7 . Link: 10.1016/J.ARCHGER.2005.01.003
69. R. Hakkak, S. Korourian (2012). Abstract B61: Effects of anti-obesity dietary supplement DHEA on serum DHEA, DHEA-S, IGF-1 and IGFBP-3 in DMBA-induced breast cancer model.. Cancer Epidemiology, Biomarkers & Prevention, 21, . Link: 10.1158/1055-9965.DISP12-B61
70. O. Khorram, Lan Vu, S. Yen (1997). Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men.. The journals of gerontology. Series A, Biological sciences and medical sciences, 52 1,
    M1-7 . Link: 10.1093/GERONA/52A.1.M1
71. Justine Tang, Li-Ru Chen, Kuo-Hu Chen (2021). The Utilization of Dehydroepiandrosterone as a Sexual Hormone Precursor in Premenopausal and Postmenopausal Women: An Overview. Pharmaceuticals, 15, . Link: 10.3390/ph15010046
72. M. Rabijewski, L. Papierska, M. Binkowska, R. Maksym, K. Jankowska, Wioletta Skrzypulec-Plinta, W. Zgliczyński (2020). Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.. Ginekologia polska, 91 9,
    554-562 . Link: 10.5603/GP.2020.0091
73. F. Labrie, D. Archer, W. Koltun, A. Vachon, Douglas Young, L. Frenette, D. Portman, M. Montesino, I. Côté, J. Parent, L. Lavoie, A. Beauregard, C. Martel, M. Vaillancourt, J. Balser, É. Moyneur (2016). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause, 23, 243–256. Link: 10.1097/GME.0000000000000571
74. Tarig A. Elraiyah, M. Sonbol, Zhen Wang, Tagwa Khairalseed, Noor Asi, C. Undavalli, M. Nabhan, Osama Altayar, L. Prokop, V. Montori, M. Murad (2014). Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.. The Journal of clinical endocrinology and metabolism, 99 10,
    3536-42 . Link: 10.1210/jc.2014-2261
75. Ulrike Sauer, V. Talaulikar, M. Davies (2018). Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase.. Maturitas, 116,
    79-82 . Link: 10.1016/j.maturitas.2018.07.016
76. F. Labrie (2019). Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues. Menopause, 26, 220–224. Link: 10.1097/GME.0000000000001177
77. M. Morrison, E. Freeman, Hui Lin, M. Sammel (2011). Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study. Archives of Women's Mental Health, 14, 375-382. Link: 10.1007/s00737-011-0231-5
78. K. Barnhart, E. Freeman, J. A. Grisso, D. Rader, M. Sammel, S. Kapoor, J. Nestler (2000). The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.. The Journal of clinical endocrinology and metabolism, 84 11,
    3896-902 . Link: 10.1097/00006254-200004000-00020
79. D. Fedorkow (2015). ACP Journal Club. Review: In peri- or postmenopausal women, DHEA does not improve symptoms and increases androgenic side effects.. Annals of internal medicine, 162 10,
    JC9 . Link: 10.7326/ACPJC-2015-162-10-009
80. Carola S Scheffers, S. Armstrong, A. Cantineau, C. Farquhar, V. Jordan (2015). Dehydroepiandrosterone for women in the peri- or postmenopausal phase.. The Cochrane database of systematic reviews, 1,
    CD011066 . Link: 10.1002/14651858.CD011066.pub2
81. T. Søeborg, H. Frederiksen, A. Mouritsen, T. H. Johannsen, K. Main, N. Jørgensen, J. Petersen, A. Andersson, A. Juul (2014). Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults.. Clinica chimica acta; international journal of clinical chemistry, 437,
    6-13 . Link: 10.1016/j.cca.2014.06.018
82. A. Morales, J. Nolan, J. Nelson, S. S. Yen (1994). Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.. The Journal of clinical endocrinology and metabolism, 78 6,
    1360-7 . Link: 10.1210/JCEM.78.6.7515387
83. S. Haffner, S. Moss, B. Klein, R. Klein (1996). Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care, 19, 1045 - 1050. Link: 10.2337/diacare.19.10.1045
84. M. Glisic, L. Z. Rojas, Eralda Asllanaj, Kris G. Vargas, M. Kavousi, M. Ikram, B. Fauser, J. Laven, T. Muka, Oscar H. Franco (2018). Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women.. International journal of cardiology, 261,
    189-195 . Link: 10.1016/j.ijcard.2018.03.008
85. S. M. Haffner, Polly A. Newcomb, Pamela M. Marcus, B. E. Klein, R. Klein (1995). Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women.. American journal of epidemiology, 142 9,
    925-34 . Link: 10.1093/OXFORDJOURNALS.AJE.A117740
86. M. Emami, M. Safabakhsh, M. Khorshidi, Omid Moradi Moghaddam, S. H. Mohammed, Meysam Zarezadeh, S. Alizadeh (2021). Effect of bariatric surgery on endogenous sex hormones and sex hormone-binding globulin levels: a systematic review and meta-analysis.. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, , . Link: 10.1016/j.soard.2021.05.003
87. I. Wiegratz, E. Kutschera, J. H. Lee, C. Moore, U. Mellinger, U. Winkler, Herbert Kuhl (2003). Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.. Contraception, 67 1,
    25-32 . Link: 10.1016/S0010-7824(02)00436-5
88. P. Casson, K. Elkind-Hirsch, J. Buster, P. Hornsby, S. Carson (1997). Effect of Postmenopausal Estrogen Replacement on Circulating Androgens. Obstetrics & Gynecology, 90, 995–998. Link: 10.1016/S0029-7844(97)00538-3
89. A. Vidal-Puig, M. Muñoz-Torres, F. Escobar-Jiménez, M. Requena, C. García-Calvente, E. Torres-Vela (1992). Dehydroepiandrosterone sulfate and other possible influencing factors that modulate sex hormone-binding globulin levels in the hirsute patient. The Journal of Steroid Biochemistry and Molecular Biology, 42, 607-611. Link: 10.1016/0960-0760(92)90451-N
90. S. Plymate, R. Hoop, R. E. Jones, L. Matej (1990). Regulation of sex hormone-binding globulin production by growth factors.. Metabolism: clinical and experimental, 39 9,
    967-70 . Link: 10.1016/0026-0495(90)90309-Z
91. Ying Hu, P. Wan, X-Q An, Guilin Jiang (2020). Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A dose-response meta-analysis of randomized controlled trials.. Complementary therapies in medicine, ,
    102620 . Link: 10.1016/j.ctim.2020.102620
92. Gregory A. Brown, M. Vukovich, Rick L. Sharp, Tracy A. Reifenrath, Kerry A. Parsons, Douglas S. King (1999). Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men.. Journal of applied physiology, 87 6,
    2274-83 . Link: 10.1152/JAPPL.1999.87.6.2274
93. Yuan-yuan Li, Jie Ren, Na Li, Jie Liu, S. C. Tan, T. Low, Zhimin Ma (2020). A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials. Experimental Gerontology, 141, . Link: 10.1016/j.exger.2020.111110
94. K. Collomp, C. Buisson, Nicolas Gravisse, Soraya Belgherbi, Z. Labsy, M. Do, O. Gagey, S. Dufay, N. Vibarel-Rebot, M. Audran (2018). Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine, 59, 538-546. Link: 10.1007/s12020-017-1514-z
95. B. Misiak, D. Frydecka, Olga Loska, A. Moustafa, J. Samochowiec, J. Kasznia, B. Stańczykiewicz (2018). Testosterone, DHEA and DHEA-S in patients with schizophrenia: A systematic review and meta-analysis. Psychoneuroendocrinology, 89, 92-102. Link: 10.1016/j.psyneuen.2018.01.007
96. T. Bosy, K. Moore, A. Poklis (1998). The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers.. Journal of analytical toxicology, 22 6,
    455-9 . Link: 10.1093/JAT/22.6.455
97. K. Nair, R. Rizza, P. O'brien, K. Dhatariya, K. Short, A. Nehra, J. Vittone, G. Klee, A. Basu, R. Basu, C. Cobelli, G. Toffolo, C. Dalla Man, D. Tindall, L. Melton, Glenn E. Smith, S. Khosla, M. Jensen (2006). DHEA in elderly women and DHEA or testosterone in elderly men.. The New England journal of medicine, 355 16,
    1647-59 . Link: 10.1056/NEJMOA054629
98. S. Page, A. Matsumoto, W. Bremner (2007). DHEA and testosterone in the elderly.. The New England journal of medicine, 356 6,
    635; author reply 637 . Link: 10.1056/NEJMC063190
99. P. Alexandersen, J. Haarbo, C. Christiansen (1996). The relationship of natural androgens to coronary heart disease in males: a review.. Atherosclerosis, 125 1,
    1-13 . Link: 10.1016/0021-9150(96)05864-9
100. H. C. Coelingh Bennink (2023). A few certainties about testosterone in women. Climacteric, 26, 168 - 168. Link: 10.1080/13697137.2023.2167597
101. Ying Qin, Heitor O Santos, Vahid Khani, S. C. Tan, Yingpeng Zhi (2020). Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.. Nutrition, metabolism, and cardiovascular diseases : NMCD, , . Link: 10.1016/j.numecd.2020.05.015
102. M. Rabijewski, W. Zgliczyński (2005). [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study].. Endokrynologia Polska, 56 6,
     904-10 . Link:
103. J. Nestler, C. Barlascini, J. Clore, W. Blackard (1988). Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.. The Journal of clinical endocrinology and metabolism, 66 1,
     57-61 . Link: 10.1210/JCEM-66-1-57
104. S. Egert, F. Kannenberg, V. Somoza, H. Erbersdobler, U. Wahrburg (2009). Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans.. The Journal of nutrition, 139 5,
     861-8 . Link: 10.3945/jn.108.103861
105. D. Jędrzejuk, M. Mędraś, A. Milewicz, M. Demissie (2003). Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism. The Aging Male, 6, 151 - 156. Link: 10.1080/tam.6.3.151.156
106. A. Garde, Å. Hansen, L. T. Skovgaard, J. M. Christensen (2000). Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women.. Clinical chemistry, 46 4,
     551-9 . Link: 10.1093/CLINCHEM/46.4.551
107. J. Christopher-Hennings, I. Kurzman, A. Haffa, J. Kemnitz, E. Macewen (1995). The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey.. In vivo, 9 5,
     415-20 . Link:
108. M. Srinivasan, B. Irving, K. Dhatariya, Katherine A. Klaus, S. Hartman, J. Mcconnell, K. Nair, Mayo Clinic, Mayo Foundation, Minnesota Rochester (2009). Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women.. The Journal of clinical endocrinology and metabolism, 94 3,
     761-4 . Link: 10.1210/jc.2008-1774
109. H. Theobald, P. Chowienczyk, R. Whittall, S. Humphries, T. Sanders (2004). LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.. The American journal of clinical nutrition, 79 4,
     558-63 . Link: 10.1093/AJCN/79.4.558
110. R. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J. Burleson, A. Kenny (2010). Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics.. Age and ageing, 39 4,
     451-8 . Link: 10.1093/ageing/afq043